The effects of COVID-19 fear and anxiety on symptom severity, sleep quality, and mood in patients with fibromyalgia: a pilot study

Damla Cankurtaran, Nihal Tezel, Buse Ercan, Sadik Yigit Yildiz, Ece Unlu Akyuz, Damla Cankurtaran, Nihal Tezel, Buse Ercan, Sadik Yigit Yildiz, Ece Unlu Akyuz

Abstract

Background: During the COVID-19 pandemic, individuals faced psychological stress caused by fear and anxiety due to the high transmission and mortality rate of the disease, the social isolation, economic problems, and difficulties in reaching health services. Fibromyalgia (FM) is a chronic centralized pain sensitivity disorder. Psychological, physical and/or autoimmune stressors were found to increase FM symptoms. This pilot study aimed to evaluate the COVID-19 fear and anxiety level, and to examine their effect on disease severity, sleep quality, and mood in FM patients compared to control group.

Methods: This pilot study conducted as a cross-sectional study, and included 62 participants. Participants were divided into two groups: FM patient group (n = 31) and control group (n = 31). Symptom severity, sleep quality, and mood were determined using the Revised Fibromyalgia Impact Questionnaire (FIQR), Pitsburg Sleep Quality Index (PSQI), and Hospital Anxiety Depression Scale (HADS), respectively. In order to evaluate the level of COVID-19 fear and anxiety, the Fear of COVID-19 Scale (FCV-19S) and Coronavirus Anxiety Scale (CAS) were used compared to control group.

Results: FIQR, PSQI, HAD-A, HAD-D, FCV-19S and CAS scores were significantly higher in the FM group (p = 0.01). A positive significant correlation was found between FCV-19S and CAS results and FIQR, PSQI, and HAD-anx results in FM patients (p < 0.05).

Conclusion: This pilot study showed that, the individuals with FM can be more affected by psychological stress, and this situation negatively affects the symptom severity, sleep quality, and mood in FM patients, so these patients should be closely monitored in terms of psychological stressors and their effects during pandemics. More studies with more participants are necessary to describe the challenges lived by fibromyalgia population.

Keywords: COVID-19; Coronavirus anxiety scale; Fear of COVID-19 scale; Fibromyalgia; Symptom severity.

Conflict of interest statement

The authors declared they have no conflict of interest.

References

    1. World Health Organization website. (accessed 15th January 2021).
    1. Sim K, Chua HC. The psychological impact of SARS: a matter of heart and mind. CMAJ. 2004;170(5):811–812. doi: 10.1503/cmaj.1032003.
    1. Wu P, Fang Y, Guan Z, Fan B, Kong J, Yao Z, Liu X, Fuller CJ, Susser E, Lu J, Hoven CW. The psychological impact of the SARS epidemic on hospital employees in China: exposure, risk perception, and altruistic acceptance of risk. Can J Psychiatr. 2009;54(5):302–311. doi: 10.1177/070674370905400504.
    1. Kim CW, Song HR. Structural relationships among public’s risk characteristics, trust, risk perception and preventive behavioral intention: the case of MERS in Korea. Crisisnomy. 2017;13:85–95.
    1. Dubey S, Biswas P, Ghosh R, Chatterjee S, Dubey MJ, Chatterjee S, Lahiri D, Lavie CJ. Psychosocial impact of COVID-19. Diabetes Metab Syndr. 2020;14(5):779–788. doi: 10.1016/j.dsx.2020.05.035.
    1. Xiong J, Lipsitz O, Nasri F, Lui LMW, Gill H, Phan L, Chen-Li D, Iacobucci M, Ho R, Majeed A, McIntyre RS. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;277:55–64. doi: 10.1016/j.jad.2020.08.001.
    1. Talevi D, Socci V, Carai M, Carnaghi G, Faleri S, Trebbi E, di Bernardo A, Capelli F, Pacitti F. Mental health outcomes of the CoViD-19 pandemic. Riv Psichiatr. 2020;55(3):137–144. doi: 10.1708/3382.33569.
    1. Mohabbat AB, Mohabbat NML, Wight EC. Fibromyalgia and chronic fatigue syndrome in the age of COVID-19. Mayo Clin Proc Innov Qual Outcomes. 2020;4(6):764–766. doi: 10.1016/j.mayocpiqo.2020.08.002.
    1. Batres-Marroquín AB, Medina-García AC, Vargas Guerrero A, Barrera-Villalpando MI, Martínez-Lavín M, Martínez-Martínez LA. Effect of COVID-19 pandemic lockdown on fibromyalgia symptoms. J Clin Rheumatol. 2020;Publish Ahead of Print. 10.1097/RHU.0000000000001685.
    1. Di Tella M, Ghiggia A, Tesio V, Romeo A, Colonna F, Fusaro E, et al. Pain experience in fibromyalgia syndrome: the role of alexithymia and psychological distress. J Affect Disord. 2017;208:87–93. doi: 10.1016/j.jad.2016.08.080.
    1. Galvez-Sánchez CM, Montoro CI, Duschek S, Del Paso GAR. Pain catastrophizing mediates the negative influence of pain and trait-anxiety on health-related quality of life in fibromyalgia. Qual Life Res. 2020;29(7):1871–1881. doi: 10.1007/s11136-020-02457-x.
    1. Cavalli G, Cariddi A, Ferrari J, Suzzi B, Tomelleri A, Campochiaro C, de Luca G, Baldissera E, Dagna L. Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients. Rheumatology (Oxford) 2021;60(1):465–467. doi: 10.1093/rheumatology/keaa738.
    1. Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):R120. doi: 10.1186/ar2783.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Climent-Sanz C, Marco-Mitjavila A, Pastells-Peiró R, Valenzuela-Pascual F, Blanco-Blanco J, Gea-Sánchez M. Patient reported outcome measures of sleep quality in fibromyalgia: a COSMIN systematic review. Int J Environ Res Public Health. 2020;17(9):2992. doi: 10.3390/ijerph17092992.
    1. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The fear of COVID-19 scale: development and initial validation. Int J Ment Heal Addict. 2020:1–9. 10.1007/s11469-020-00270-8.
    1. Satici B, Gocet-Tekin E, Deniz ME, Satici SA. Adaptation of the fear of COVID-19 scale: its association with psychological distress and life satisfaction in Turkey. Int J Ment Heal Addict. 2020:1–9. 10.1007/s11469-020-00294-0.
    1. Nikopoulou VA, Holeva V, Parlapani E, Karamouzi P, Voitsidis P, Porfyri GN, et al. Mental health screening for COVID-19: a proposed cutoff score for the Greek version of the fear of COVID-19 scale (FCV-19S). Int J Ment Heal Addict. 2020:1–14. 10.1007/s11469-020-00414-w.
    1. Evren C, Evren B, Dalbudak E, Topcu M, Kutlu N. Measuring anxiety related to COVID-19: a Turkish validation study of the coronavirus anxiety scale. Death Stud. 2020;3:1–7. doi: 10.1080/07481187.2020.1774969.
    1. Lee SA. Coronavirus anxiety scale: a brief mental health screener for COVID-19 related anxiety. Death Stud. 2020;44(7):393–401. doi: 10.1080/07481187.2020.1748481.
    1. Cagnie B, Coppieters I, Denecker S, Six J, Danneels L, Meeus M. Central sensitization in fibromyalgia? A systematic review on structural and functional brain MRI. Semin Arthritis Rheum. 2014;44(1):68–75. doi: 10.1016/j.semarthrit.2014.01.001.
    1. Wu YL, Chang LY, Lee HC, Fang SC, Tsai PS. Sleep disturbances in fibromyalgia: a meta-analysis of case-control studies. J Psychosom Res. 2017;96:89–97. doi: 10.1016/j.jpsychores.2017.03.011.
    1. Pfefferbaum B, North CS. Mental health and the Covid-19 pandemic. N Engl J Med. 2020;383(6):510–512. doi: 10.1056/NEJMp2008017.
    1. Lee SA, Mathis AA, Jobe MC, Pappalardo EA. Clinically significant fear and anxiety of COVID-19: a psychometric examination of the coronavirus anxiety scale. Psychiatry Res. 2020;290:113112. doi: 10.1016/j.psychres.2020.113112.
    1. Arpaci I, Karataş K, Baloğlu M. The development and initial tests for the psychometric properties of the COVID-19 phobia scale (C19P-S) Personal Individ Differ. 2020;164:110108. doi: 10.1016/j.paid.2020.110108.
    1. Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020;7(4):e21. doi: 10.1016/S2215-0366(20)30090-0.
    1. Hruschak V, Flowers KM, Azizoddin DR, Jamison RN, Edwards RR, Schreiber KL. Cross-sectional study of psychosocial and pain-related variables among patients with chronic pain during a time of social distancing imposed by the coronavirus disease 2019 pandemic. Pain. 2021;162(2):619–629. doi: 10.1097/j.pain.0000000000002128.
    1. Beard C, Millner AJ, Forgeard MJ, Fried EI, Hsu KJ, Treadway MT, et al. Network analysis of depression and anxiety symptom relationships in a psychiatric sample. Psychol Med. 2016;46(16):3359–3369. doi: 10.1017/S0033291716002300.
    1. Ramezanzadeh F, Aghssa MM, Abedinia N, Zayeri F, Khanafshar N, Shariat M, Jafarabadi M. A survey of relationship between anxiety, depression and duration of infertility. BMC Womens Health. 2004;4(1):9. doi: 10.1186/1472-6874-4-9.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever